Yaz Articles
Schering AG to focus on special markets
20 April 2001
Schering AG to "grow faster than market"
16 March 2001
Healthy harvest of New Chemical Entities in 2000
2 January 2001
Stock Commentary Europe
28 September 2000
Stock Commentary Europe
14 September 2000
Europe approves Schering's Yasmin, US approvable letter for Imavist
7 September 2000
FDA requests more data for Schering's Yasmin
20 July 2000
FDA requests more data for Schering's Yasmin
20 July 2000
Schering's Yasmin approved in the Netherlands
13 April 2000
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- New study shows UCB's Neupro reduces NSBP in RLS patient
